Keyphrases
Nasopharyngeal Carcinoma
100%
Epstein-Barr Virus
100%
Human Leukocyte Antigen
100%
Gene Transfer
100%
Virus-specific T Cells
100%
T-cell Receptor Gene
100%
LMP2
66%
T Cells
33%
T Cell Receptor
33%
Clinical Setting
16%
Autoimmunity
16%
Nasopharyngeal Carcinoma Cells
16%
Tumor Growth
16%
Cytotoxicity
16%
In Vitro Culture
16%
Specific T Cells
16%
CD4+ T Cells
16%
Post-transplant Lymphoproliferative Disorder
16%
CD8+
16%
Advanced Nasopharyngeal Carcinoma
16%
New Human Leukocyte Antigen Allele
16%
Epithelial Tumor
16%
Optimized Expression
16%
Lymphoblastoid Cell Lines
16%
Lymphoma
16%
Viral Antigens
16%
Self-antigens
16%
Epstein-Barr Virus-associated Malignancy
16%
Engineered T Cells
16%
T Cell Targeting
16%
Antigen-specific
16%
Mouse Model
16%
Modified Forms
16%
Cytokine Release
16%
Effective Treatment
16%
Viral Proteins
16%
Immunology and Microbiology
T Cell
100%
Gene Transfer
100%
Human Leukocyte Antigen
100%
T Cell Receptor
100%
Epstein Barr Virus
100%
CD8
14%
Allele
14%
T-Helper Cell
14%
Wild Type
14%
Cytotoxicity
14%
Virus Antigen
14%
Antigen Specificity
14%
Viral Protein
14%
Nasopharyngeal Carcinoma Cell Line
14%
Lymphoblastoid Cell Line
14%
Mouse Model
14%
Cytokine Release
14%
Autoimmunity
14%
Immunology
14%
Biochemistry, Genetics and Molecular Biology
Receptor Gene
100%
Epstein Barr Virus
100%
T Cell Receptor
100%
T Cell
100%
Human Leukocyte Antigen
100%
Avidity
25%
Allele
12%
Autoimmunity
12%
Tumor Progression
12%
Cytokine Release
12%
CD8
12%
Mouse Model
12%
Wild Type
12%
Viral Protein
12%
Cytotoxicity
12%
Antigen Specificity
12%
CD4
12%